This day will cover aspects of antimicrobial resistance, antimicrobial stewardship, management of clinical infections and data. The day will focus on issues predominant in secondary and primary care Patients coming to hospital with infections often present with a variety of challenges, including resistant organisms, deterioration and not responding to first line treatment, or other complications. As a pharmacist you are optimally placed to intervene for the benefit of your patients and manage medication risks.
A wide range of topical areas will be covered such as Gram negative bacteraemias, the impact of behaviour change on antibiotic prescribing, difficulties of antibiotic procurement and a not to be missed session on influenza: predicted strains for winter 2018/2019.
For the first time during a PIN Masterclass, there will be different plenary sessions to choose from so that you can pick and choose which sessions you attend:
CRP diagnostics in primary care
Sepsis and Respiratory Tract Infections
New NICE Infection Guidelines
Antifungals and Resistance
Improving Antimicrobial Stewardship in Primary Care using ePACT2
This event will be delivered by way of presentations, case studies, panel discussion and debates.
This event has been designed for primary and secondary care pharmacists involved in the care of patients with infections and for those working in the area of antimicrobial stewardship. The event is suitable for pharmacists who have recently specialised as well as those who are working at early advanced levels.
At the end of this masterclass, participants will be able to:
- Discuss the principles and application of concordance and adherence to support self-management of medicines, with particular reference to the development of antimicrobial resistance, e.g. completing antibiotic course and not sharing antibiotics with others.
- Summarise the pathophysiological events underlying and leading to infection.
- Outline common infecting organisms for different body systems and the key antibiotics used for common infections.
- Describe the process of antimicrobial resistance.
- Discuss the differentiation between primary and secondary respiratory infections i.e. community and hospital- acquired pneumonia, aspiration pneumonia, and exacerbation of chronic obstructive pulmonary disease/asthma, and the use of severity scales.
- Outline the basic pathophysiology, prevention and risk factors for the development of influenza including pandemic flu; and the mechanism of action, pharmacology, pharmacokinetic characteristics and clinical use of treatments of influenza.
- Define antimicrobial stewardship (AMS) including its role in tackling antimicrobial resistance, key elements of an AMS programme and its application in hospital and community settings.
- Discuss the pathophysiology and risk factors for the development of infections due to resistant organisms e.g. methicillin-resistant Staphylcococcus aureus (MRSA), carbapenem-resistant enterobacteriaceae (CRE).
- Discuss the mechanism of action, pharmacology and pharmacokinetic characteristics and clinical use of treatments for infections due to resistant organisms.
- Review and risk assess suitable alternative medications and/or formulations during periods of local or national supply shortages.
- Outline the roles of external organisations in pharmaceutical purchasing and supply e.g. purchasing and Supply Agency pharmaceutical team, hubs and other regional organisations.
- Discuss supply chain management theory.
- Discuss the current status of GNBSI and the role of new antibiotics.
- Explain the impact of behaviour change on antimicrobial stewardship.
- Discuss inappropriate prescribing and its impact on antimicrobial resistance.
- Discuss sepsis and respiratory infections treatments.
- Describe antifungal diagnostics and resistance.
- Outline NICE infection guidelines and relevant content.
- Discuss the role of CRP diagnostics and its impact on antimicrobial resistance.
- Outline the influenza programme for 2018/19.
- Discuss the global antimicrobial shortages and it impact on the NHS.
Peer discussion opportunities will be available at this event, which can also be used towards your CPD and portfolios. Advanced booking essential.
Attending this event will help you advance your professional practice and could be used as evidence in your RPS Faculty and GPhC revalidation portfolios. The day will cover Core Advanced and Specialist areas of knowledge.
This event has been financially supported by the pharmaceutical industry, including:
Stand sponsors have no input into the content of this event. Promotional stands from these companies will be exhibited at this event. Other pharmaceutical companies have been invited to support this day.